Search details
1.
Loss of ATG4B and ATG4A results in two-stage cell cycle defects in pancreatic ductal adenocarcinoma cells.
J Cell Sci
; 136(19)2023 10 01.
Article
in English
| MEDLINE | ID: mdl-37701987
2.
New insights into the biology and development of lung cancer in never smokers-implications for early detection and treatment.
J Transl Med
; 21(1): 585, 2023 08 31.
Article
in English
| MEDLINE | ID: mdl-37653450
3.
An ErbB2 splice variant lacking exon 16 drives lung carcinoma.
Proc Natl Acad Sci U S A
; 117(33): 20139-20148, 2020 08 18.
Article
in English
| MEDLINE | ID: mdl-32727899
4.
Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance.
Proc Natl Acad Sci U S A
; 116(19): 9433-9442, 2019 05 07.
Article
in English
| MEDLINE | ID: mdl-31000598
5.
Developmental transcription factor NFIB is a putative target of oncofetal miRNAs and is associated with tumour aggressiveness in lung adenocarcinoma.
J Pathol
; 240(2): 161-72, 2016 10.
Article
in English
| MEDLINE | ID: mdl-27357447
6.
Synthetic lethality in lung cancer and translation to clinical therapies.
Mol Cancer
; 15(1): 61, 2016 Sep 29.
Article
in English
| MEDLINE | ID: mdl-27686855
7.
Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis.
Mol Cancer
; 15(1): 67, 2016 10 27.
Article
in English
| MEDLINE | ID: mdl-27784305
8.
Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins.
Proc Natl Acad Sci U S A
; 109(47): 19408-13, 2012 Nov 20.
Article
in English
| MEDLINE | ID: mdl-23129625
9.
Ubiquitination, localization, and stability of an anti-apoptotic BCL2-like protein, BCL2L10/BCLb, are regulated by Ubiquilin1.
Proc Natl Acad Sci U S A
; 109(3): E119-26, 2012 Jan 17.
Article
in English
| MEDLINE | ID: mdl-22233804
10.
Activation of GATA binding protein 6 (GATA6) sustains oncogenic lineage-survival in esophageal adenocarcinoma.
Proc Natl Acad Sci U S A
; 109(11): 4251-6, 2012 Mar 13.
Article
in English
| MEDLINE | ID: mdl-22375031
11.
Superoxide dismutase 1 (SOD1) is a target for a small molecule identified in a screen for inhibitors of the growth of lung adenocarcinoma cell lines.
Proc Natl Acad Sci U S A
; 108(39): 16375-80, 2011 Sep 27.
Article
in English
| MEDLINE | ID: mdl-21930909
12.
Prevalence and Therapeutic Targeting of High-Level ERBB2 Amplification in NSCLC.
J Thorac Oncol
; 19(5): 732-748, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38154514
13.
Tandem mass tag-based thermal proteome profiling for the discovery of drug-protein interactions in cancer cells.
STAR Protoc
; 4(1): 102012, 2023 03 17.
Article
in English
| MEDLINE | ID: mdl-36856765
14.
Delineating spatial cell-cell interactions in the solid tumour microenvironment through the lens of highly multiplexed imaging.
Front Immunol
; 14: 1275890, 2023.
Article
in English
| MEDLINE | ID: mdl-37936700
15.
Characterizing the secretome of EGFR mutant lung adenocarcinoma.
Front Oncol
; 13: 1286821, 2023.
Article
in English
| MEDLINE | ID: mdl-38260835
16.
Combination Therapy With MDM2 and MEK Inhibitors Is Effective in Patient-Derived Models of Lung Adenocarcinoma With Concurrent Oncogenic Drivers and MDM2 Amplification.
J Thorac Oncol
; 18(9): 1165-1183, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37182602
17.
Methionine-producing tumor micro(be) environment fuels growth of solid tumors.
Cell Oncol (Dordr)
; 46(6): 1659-1673, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37318751
18.
MET Exon 14 Splice-Site Mutations Preferentially Activate KRAS Signaling to Drive Tumourigenesis.
Cancers (Basel)
; 14(6)2022 Mar 08.
Article
in English
| MEDLINE | ID: mdl-35326531
19.
MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression.
NPJ Precis Oncol
; 6(1): 88, 2022 Nov 23.
Article
in English
| MEDLINE | ID: mdl-36418460
20.
CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development.
Oncoimmunology
; 11(1): 2010905, 2022.
Article
in English
| MEDLINE | ID: mdl-35481284